Skipping the line: Bringing MET exon 14 skipping mutations to the forefront of targeted therapy

Elaine Shum; Balazs Halmos

doi:10.21037/tcr.2016.03.12

Skipping the line: Bringing MET exon 14 skipping mutations to the forefront of targeted therapy

Elaine Shum, Balazs Halmos

Oncology

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	110-116
Number of pages	7
Journal	Translational Cancer Research
Volume	5
Issue number	2
DOIs	https://doi.org/10.21037/tcr.2016.03.12
State	Published - Apr 1 2016

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/tcr.2016.03.12

Cite this

@article{9fa00698671f400cb868eee1dc749d74,

title = "Skipping the line: Bringing MET exon 14 skipping mutations to the forefront of targeted therapy",

author = "Elaine Shum and Balazs Halmos",

year = "2016",

month = apr,

day = "1",

doi = "10.21037/tcr.2016.03.12",

language = "English (US)",

volume = "5",

pages = "110--116",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

number = "2",

}

TY - JOUR

T1 - Skipping the line

T2 - Bringing MET exon 14 skipping mutations to the forefront of targeted therapy

AU - Shum, Elaine

AU - Halmos, Balazs

PY - 2016/4/1

Y1 - 2016/4/1

UR - http://www.scopus.com/inward/record.url?scp=84966290810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966290810&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.03.12

DO - 10.21037/tcr.2016.03.12

M3 - Editorial

AN - SCOPUS:84966290810

SN - 2218-676X

VL - 5

SP - 110

EP - 116

JO - Translational Cancer Research

JF - Translational Cancer Research

IS - 2

ER -

Skipping the line: Bringing MET exon 14 skipping mutations to the forefront of targeted therapy

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this